Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638 exhibit enhanced potency against neurogenic inflammation in dura mater
- 29 October 1993
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 626 (1) , 303-305
- https://doi.org/10.1016/0006-8993(93)90591-a
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The synthesis of a conformationally restricted analog of the anti-migraine drug sumatriptanTetrahedron Letters, 1992
- Synthesis and serotonergic pharmacology of the enantiomers of 3-[(N-methylpyrrolidin-2-yl)methyl]-5-methoxy-1H-indole: discovery of stereogenic differentiation in the aminoethyl side chain of the neurotransmitter serotoninJournal of Medicinal Chemistry, 1992
- Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraineTrends in Pharmacological Sciences, 1992
- Mode of action of the anti-migraine drug sumatriptanTrends in Pharmacological Sciences, 1991
- CP‐93,129, a potent and selective 5‐HT1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea‐pig dura materBritish Journal of Pharmacology, 1991
- Treatment of Migraine Attacks with SumatriptanNew England Journal of Medicine, 1991
- Further characterization of the putative 5‐HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura materBritish Journal of Pharmacology, 1991
- Role of 5‐HT1‐like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptanBritish Journal of Pharmacology, 1991
- Ergot alkaloids block neurogenic extravasation in dura mater: Proposed action in vascular headachesAnnals of Neurology, 1988